Abdominal Pain News and Research

RSS
Abdominal pain is traditionally described by its chronicity (acute or chronic), its progression over time, its nature (sharp, dull, colicky), its distribution (by various methods, such as abdominal quadrant (left upper quadrant, left lower quadrant, right upper quadrant, right lower quadrant) or other methods that divide the abdomen into nine sections), and by characterization of the factors that make it worse, or alleviate it.
FDA approves first vaginal ring contraceptive that can be used for one year

FDA approves first vaginal ring contraceptive that can be used for one year

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

Study: 11% of IBS-D patients suffer from suicidal thinking when their condition is bad

Study: 11% of IBS-D patients suffer from suicidal thinking when their condition is bad

FDA approves potassium chloride oral solution as first generic drug to receive CGT designation

FDA approves potassium chloride oral solution as first generic drug to receive CGT designation

Probiotic use could result in disorienting brain fogginess and rapid belly bloating

Probiotic use could result in disorienting brain fogginess and rapid belly bloating

Clinical trial to use stem cell transplants for treating Crohn's disease

Clinical trial to use stem cell transplants for treating Crohn's disease

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

New approach to cultivate hypoallergenic tomato and strawberry varieties

New approach to cultivate hypoallergenic tomato and strawberry varieties

Researchers discover immune cells that create and sustain chronic inflammatory bowel disease

Researchers discover immune cells that create and sustain chronic inflammatory bowel disease

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Alnylam announces new positive results from Phase 1/2 study of lumasiran in patients with PH1

Alnylam announces new positive results from Phase 1/2 study of lumasiran in patients with PH1

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

Infant formulas containing fructose pose risk to babies with hereditary fructose intolerance

Infant formulas containing fructose pose risk to babies with hereditary fructose intolerance